Product Details
Meropenem for Injection
Meropenem1 g/Vial
Powder for Solution for Injection
DIN/PIN/NPN
02378795
Manufacturer
Sandoz Canada Inc.
Formulary Listing Date
2021-10-29
Unit Price
47.9900
Amount MOH Pays
47.9900
Coverage Status
Off-Formulary Interchangeable Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
J01DH02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02421526 | Taro-Meropenem | 47.9900 | 47.9900 |
| 02218496 | Merrem | NA | NA |
| 02378795 | Meropenem for Injection | 47.9900 | 47.9900 |
| 02493349 | Meropenem for Injection | 47.9900 | 47.9900 |
| 02536374 | Meropenem for Injection | 47.9900 | 47.9900 |
LU Clinical Criteria
NOEAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |